Effect of glucagon on renal excretion of oxypurinol and purine bases

Journal of Rheumatology

Volumn 24, Issue 4, 1997, Pages 708-713

  Yamamoto, Tetsuya ^a   Moriwaki, Yuji ^a   Takahashi, Sumio ^a   Tsutsumi, Zenta ^a   Hiroishi, Keisai ^a   Yamakita, Jun Ichi ^a   Nakano, Takashi ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Glucagon; Oxypurinol; Purine bases; Uric acid; Xanthine

Indexed keywords

ALLOPURINOL; GLUCAGON; OXIPURINOL; URIC ACID; XANTHINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; BLOOD GLUCOSE; CHLORINE; CREATININE; CYCLIC AMP; GLUCAGON; HUMANS; HYPOXANTHINE; KIDNEY; MALE; NITROGEN; OXYPURINOL; PHOSPHATES; PURINONES; SODIUM; URIC ACID; XANTHINE; XANTHINES;

EID: 0030900683     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cohen JL, Vinik A, Faller J. Fox IH: Hyperuricemia in glycogen storage disease type 1 - Contributions by hypoglycemia and hyperglucagonemia to increased urate production. J Clin Invest 1985;75:251-7.
2. Roe TF, Kogut MD: The pathogenesis of hyperuricemia in glycogen storage disease, type I. Pediatr Res 1977;11:664-9.
3. Moriwaki Y, Yamamoto T, Takahashi S, Suda M, Higashino K: Effect of glucose infusion on the renal transport of purine bases and oxypurinol. Nephron 1995;69:424-7.
4. Yamamoto T, Moriwaki Y, Takahashi S, Yamakita J, Higashino K: Effect of amino acids on the urinary excretion of purine bases and oxypurinol. Nephron 1996;73:41-7.
5. Berlinger WG, Park GD, Spector R: The effect of dietary protein on the clearance of allopurinol and oxypurinol. New Engl J Med 1985;313:771-6.
6. Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Higashino K: Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol and purine bases between dietary intake and fasting. Int J Pharmacol Ther 1996;34:157-62.
7. Yamamoto T, Moriwaki Y, Takahashi S, Suda M, Higashino K: Ethanol as a xanthine dehydrogenase inhibitor. Metabolism 1995;44:779-85.
8. Yamamoto T, Moriwaki Y, Takahashi S, Hada T, Higashino K: Renal excretion of purine bases: Effects of probenecid, benzbromarone and pyrazinamide. Nephron 1988;48:116-20.
9. Auscher C, Pasquier C, Pehuet P, Delbarre F: Study of urinary pyrazinamide metabolites and their action on the renal excretion of xanthine and hypoxanthine in a xanthinuric patient. Biomedicine 1978;28:129-33.
10. Boden G, Rezvani I, Owen OE: Effects of glucagon on plasma amino acids. J Clin Invest 1984;73:785-93.
11. Coulson R: Metabolism and excretion of exogenous adenosine 3′-5′-monophosphate and guanosine 3′-5′-monophosphate; studies in the isolated perfused rat kidney and in the intact rat. J Biol Chem 1976;251:4958-67.
12. Butlen D, Jard S: Renal handling of 3′-5′-cyclic AMP in the rat. The possible role of luminal 3′-5′ cyclic AMP in the tubular reabsorption of phosphate. Pflugers Arch 1972;331:172-90.
13. Broadus AE, Kaminsky NI, Northcutt RC, Hardman JG, Sutherland EW, Liddle GW: Effects of glucagon on adenosine 3′-5′-monophosphate and guanosine 3′-5′-monophosphate in human plasma and urine. J Clin Invest 1970.-49:2237-45.
14. Butlen D, Morel F: Glucagon receptors along the nephron: [125]glucagon binding in rat tubules. Pflugers Arch 1985;404:348-53.
15. Bailly C, Imbert-Teboul M, Chabardes D, et al: The distal nephron of rat kidney. A target site for glucagon. Proc Natl Acad Sci USA 1980;77:3422-4.
16. Premen AJ: Importance of the liver during glucagon-mediated increases in canine renal hemodynamics. Am J Physiol 1985;249:F319-22.
17. Uranga J, Fuenzalida R, Rapoport AL, del Castillo E: Effect of glucagon and glomerulopressin on the renal function of dog. Horm Metab Res 1979;11:275-9.
18. de Rouffignac C, Elalouf JM, Roinel N: Glucagon inhibits water and NaCl transports in the proximal convoluted tubule of the rat kidney. Pflugers Arch 1991;419:472-7.
19. Krusell LR, Christensen CK, Pedersen OL: Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls - a proximal tubular effect? Eur J Clin Pharmacol 1987;32:121-6.
20. Krusell LR, Jespersen LT, Schmitz A, Thomsen K, Pedersen OL: Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine. Hypertension 1987;10:577-81.
21. Balakrishnan VS, Coles GA, Williams JD: A potential role for endogenous adenosine in control of human glomerular and tubular function. Am J Physiol 1993;265:F504-10.